Diabetes and Cardiovascular Disease in 2022

October 25, 2022 6:00 pm – 7:00 pm
Zoom – Digital Delivery, Vancouver BC

People with diabetes are three times more likely to die of cardiovascular disease, with increased risk of high blood pressure, narrowing of the arteries, coronary artery disease and stroke. Join us on October 25, 2022 as we learn how to apply the latest Canadian guidelines when selecting pharmacological treatments for patients with cardiovascular disease with or without type 2 diabetes, review factors to consider when choosing diabetes medications and review changes in the guidelines and what it means for pharmacists.

Learning Objectives

At the end of this program, participants will be better able to:

  • Apply the latest Canadian guidelines when selecting pharmacological treatments for patients with cardiovascular disease with or without type 2 diabetes 
  • Review factors to consider when choosing diabetes medications in cardiometabolic patients with type 2 diabetes 
  • Review changes in the guidelines and what this means for pharmacists 

Speaker: Dr. Andrew Ignaszewski

Dr. lgnaszewski received his medical training in Poland. He came to Canada in 1983 and completed Internal Medicine training at Dalhousie University in Halifax, Nova Scotia before moving to University of Alberta where he finished Adult Cardiology training. He was recruited for medical leadership of a premier cardiac rehabilitation and prevention program at St. Paul's Hospital, Vancouver, British Columbia in 1994.

His other areas of interest include management of severe heart failure and heart transplantation, including novel multidisciplinary approaches to the treatment of the disease with specialized clinics and quality improvement measures. Dr. lgnaszewski is the Director of the Heart Function Clinic at St. Paul's Hospital and a former director of
the UBC Heart Transplant Program at St. Paul's Hospital. He is also Provincial Lead in Heart Failure.

Dr. lgnaszewski's research interests are cardiac rehabilitation and prevention, heart failure and patient outcomes following various cardiovascular interventions. He has published 77 papers and 128 abstracts in these areas.

Dr. lgnaszewski is also involved in the teaching of medical students and medical residents at St. Paul's Hospital. He has received teaching awards from the University of British Columbia such as Best Teacher during a clinical rotation, Excellence in Clinical Teaching Skills and Teacher of the Year Awards. He has also received an award for Excellence in health Promotion from Doctors of BC.

Learning Hours

This program is non-accredited. Total learning hours is estimated at 1.0 hours. Participants will receive a letter of participation after completion of the survey at the end of the webinar.

This learning program received a financial support from Boehringer Ingleheim. This event will be moderated by Ann Johnston (MPharm, RPh), Senior Manager, Pharmacy Practice Support at the BC Pharmacy Association.

Registration Information

This event is complimentary to members.

Registration closes an hour prior to the start of the webinar, at 5:00 PM. On the day of the webinar, you will receive a link to the webinar by email. The email will come from and could be in your junk folder.

Please Note: A BCPhA account is required to register for this event. If you do not have a login account or if you are unsure if you have a login, please fill out the Account Creation Form and a member of the BCPhA team will contact you. Accounts can be created free of charge with valid College registration.